RANKL-RANK interaction inhibitors (Shanghai Second Medical University/Univ of Chinese Academy of Sciences)

N/A

Report date: 2025/03/20 10:01:19
NME

Base Information

Drug NameRANKL-RANK interaction inhibitors (Shanghai Second Medical University/Univ of Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity of Chinese Academy of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Chinese Academy of SciencesShanghai Jiao Tong University School of Medicine
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A